Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Sildenafil

Research Leaders

9 sponsors active, led by Medical College of Wisconsin

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 2 (2)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Sildenafil1
  • Hyperbaric Oxygen Therapy1
  • Mandated Rest Intervention1
  • Metacognitive Therapy1

Active Sponsors

  • Medical College of Wisconsin1
  • Center for Neuroscience and Regenerative Medicine (CNRM)1
  • United States Naval Medical Center, Portsmouth1
  • Uniformed Services University of the Health Sciences1
  • Norwegian University of Science and Technology1

Top Investigators

Related Conditions

  • Mild Traumatic Brain Injury2
  • Brain Injuries1
  • Concussion1
  • Traumatic Brain Injury1
  • Postconcussive Symptom1

Activity Timeline